when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

MIFEPRISTONE · news · pharmadog

← back to MIFEPRISTONE

News mentioning MIFEPRISTONE

61 stories

7dTrump uses ‘contested’ power to cut more funding to HHSstat

10dOpinion: FDA commissioner nominee Heidi Overton is ignoring the science on abortion drugstat

10dSTAT+: Pharmalittle: We’re reading about a reticent FDA commish nominee, a Novo deal, and morestat

10dFederal judge rolls back landmark disability protectionsstat

11dFDA nominee Overton parries vaccine questions at Senate hearingbiopharma dive

11dSTAT+: FDA commissioner nominee Heidi Overton keeps opinions to herself in Senate hearingstat

11dUS senators grill FDA nominee Overton on ability to ‘stand up’ to Trumpbiospace

11dTrump's FDA pick Heidi Overton calls vaccines, mifepristone safe and effective in confirmation hearingfiercebiotech

25dSTAT+: Pharmalittle: We’re reading about a Novartis investor seeking a shake-up, a Gilead setback, and morestat

Sep 2, 26Teva claims success in celiac study; BioMarin, Ascendis settle patent disputebiopharma dive

Aug 27, 26STAT+: Cassidy criticizes FDA oversight of abortion pill manufacturers in new reportstat

Aug 26, 26Opinion: Many post-Dobbs abortion fears have not come to pass. What does that mean for advocates?stat

Jul 27, 26Virginia federal judge says FDA should reconsider mifepristone restrictionsendpoints

Jul 21, 26Biotech industry leaders file brief backing FDA against ‘malicious’ mifepristone challengefiercebiotech

Jul 21, 26A renewed push from the right against abortion pillsstat

Jun 5, 26STAT+: Pharmalittle: We’re reading about Roche accusing U.S. of ‘blackmail,’ a ruling on skinny labels, and morestat

May 19, 26The latest on Ebola: A travel ban and an old vaccinestat

May 18, 26Texas is opening up a detransition clinicstat

May 18, 26Opinion: ‘Patient autonomy’ has nothing to do with childhood vaccine policiesstat

May 18, 26Opinion: How to restore credibility to the CDC’s vaccine advisory committeestat

May 16, 26Opinion: The cloudy truth about ‘blue zones’stat

May 16, 26Opinion: Marty Makary misunderstood something fundamental about the FDAstat

May 15, 26Supreme Court preserves access to abortion pill by mailbiopharma dive

May 15, 26Opinion: First hantavirus, now Ebola: What two outbreaks reveal about global preparednessstat

May 15, 26A new Ebola outbreak is confirmed in a remote Congo province, with 65 deaths recordedstat

May 15, 26Opinion: Telehealth abortion with mifepristone continues, with backup plans still in placestat

May 15, 26Mail-order abortion pills are legal (for now)stat

May 15, 26Supreme Court preserves mail access for abortion pillendpoints

May 14, 26Supreme Court preserves access to widely used abortion pill, while lawsuit plays outstat

May 14, 26STAT+: Three years of declining overdose deaths begets cautious optimism and some concernsstat

← prevpage 1 of 3next →